A Team Of Specialists

P. William Conrad, M.D. PhD. Curriculum Vitae - Go Back

Education and Training:

1992-1996 DePauw University, Greencastle, IN

1996-2000 University of Cincinnati College of Medicine, Cincinnati, OH

Ph.D. in Molecular and Cellular Physiology

2000-2004Case Western Reserve University School of Medicine, Cleveland, OH

M.D. degree

2004-2005Transitional Internship

The Western Pennsylvania Hospital, Pittsburgh, PA

2005-2008 Resident in Ophthalmology

University of Michigan, Kellogg Eye Center, Ann Arbor, MI

2008-2010 Fellow, Vitreoretinal surgery

University of Michigan, Kellogg Eye Center, Ann Arbor, MI

 

Appointments:

2010-present Clinical Instructor of Ophthalmology, University of Pittsburgh School of Medicine

Membership in Professional Societies:

2010-present Pittsburgh Ophthalmology Society

2010-present American Academy of Ophthalmology

2011-present American Society of Retina Specialists

2011-present Pennsylvania Medical Society

 

Certification:

2010 Diplomat, American Board of Ophthalmology

Medical Licensure:

2005-2010 State of Michigan

2010-present State of Pennsylvania

Honors:

2004 Alpha Omega Alpha Honor Medical Socity

2000 Doane Award as outstanding graduate student in the Department of Molecular and Cellular Physiology, University

of Cincinnati

 

Publications:

1.Conrad, P.W., Zacks, D.N and Johnson, M.W. (2008) Intravitreal Bevacizumab has Initial Clinical Benefit Lasting Eight Weeks in Eyes with Neovascular Age-Related Macular Degeneration” Clinical Ophthalmol. 4, 727-33

2.Oefelein, M.G., Ricchiuti, V., Conrad, W. and Resnick, M.I. (2002) “Skeletal fractures negatively correlate with overall survival in men with prostate cancer. Urol. 168, 1005-7

3.Oefelein, M.G., Ricchiuti, V.S., Conrad, P.W., Goldman, H., Bodner, D., Resnick, M.I. and Seftel, A. (2002) Clinical predictors of androgn-independent prostate cancer and survival in the prostate-specific antigen era Urology 60, 120-4

4.Oefelein, M.G., Ricchiuti, V.S., Conrad, P.W., Seftel, A., Bodner, B., Goldman, H. and Resnick, M. (2001) Skeletal fracture associated with androgen suppressioninduced osteoporosis:the clinical incidence and risk factors for patients with prostate cancer J. Urol. 166, 662-3

5.Conrad, P.W., Conforti, L., Kobayashi, S., Beitner-Johnson, D., Rust, R.T., Yuan, Y., Kim, H., Kim, R.H., Seta, K., and Millhorn, D.E. (2001) “The molecular basis of O(2)-sensing and hypoxia tolerance in pheochromocytoma cells Comp Biochem Physiol B Biochem Mol Biol. 128, 187-204

6.Beitner-Johnson, D., Seta, K., Yuan, Y., Kim, H-W., Rust, R.T., Conrad, P.W., Kobayashi, S., and Millhorn, D.E. (2001) Identification of hypoxia-responsive genes in a dopaminergic cell line by subtractive cDNA libraries and microarray analysis Parkinsonism Relat Disord. 7 273-281

7. Conrad, P.W., Millhorn, D.E., Beitner-Johnson, D. (2000) Novel regulation of p38g by dopamine D2 receptors during hypoxia Cell Signal. 12, 463-467

8.Conrad, P.W., Millhorn, D.E., and Beitner-Johnson, D. (2000) Hypoxia differentially regulates the Mitogen- and Stress-Activated Protein Kinases: Role of Ca2+/CaM in the activation of MAPK and p38 Adv Exp Med Biol. 475, 293-302

9. Millhorn, D.E., Beitner-Johnson, D., Conforti, L., Conrad, P.W., Kobayashi, S., Yuan, Y., and Rust, R. (2000) Gene regulation during hypoxia in excitable oxygen-sensing cells: Depolarization-transcription coupling Adv Exp Med Biol. 475, 131-42

10.Conrad, P.W., Freeman, T.L., Beitner-Johnson, D., and Millhorn, D.E. (1999) EPAS1 trans-activation during hypoxia requires p42/p44 MAPK J. Biol. Chem. 274, 33709-33713

11.Conrad, P.W., Rust, R.T., Han, J., Millhorn, D.E., and Beitner-Johnson, D. (1999) Selective activation of p38 and p38g by hypoxia: A role for p38 and p38g in regulation of cyclin D1 by hypoxia in PC12 cells.J. Biol. Chem. 274, 23570-23576

12.Conforti, L., Kobayashi, S., Beitner-Johnson, D., Conrad, P. W., Freeman, T. L., and Millhorn, D. E. (1999) Regulation of gene expression and secretory functions in oxygen-sensing PC12 cellsResp. Phys. 115, 249-260